Company / Operating Margin
TherapeuticsMD, Inc. Operating Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-654.6%
FY2024
5-year range
-3092.8% / 1.7%
FY2020-FY2024
Trend
-38606.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -38606% YoY in FY2024, a notable deviation from the 9-year average annual change of -4387%.
Based on SEC 10-K filings.
-654.6% in FY2024 with a 5-year CAGR of -191.9%.
Improved from -3092.8% to -654.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -350.1pp
- 5-Year Change
- -191.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 38606.5% year-over-year.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -654.6% | -38606.5% |
| FY2023 | 1.7% | +100.1% |
| FY2022 | -3092.8% | -915.5% |
| FY2021 | -304.6% | +62.3% |
| FY2020 | -808.9% | -74.8% |
| FY2019 | -462.7% | +0.8% |
| FY2018 | -466.3% | -10.2% |
| FY2017 | -422.9% | -17.6% |
| FY2016 | -359.6% | -22.3% |
| FY2015 | -294.1% | +30.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026